{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:11:10Z","timestamp":1791612670114,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Diagnostic Radiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1067\/j.cpradiol.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:16:37Z","timestamp":1530126997000},"page":"379-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia"],"prefix":"10.1067","volume":"48","author":[{"given":"Ming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa B.","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Roarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-2081","authenticated-orcid":false,"given":"Ba D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/j.cpradiol.2018.06.005_bib0001","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","article-title":"Tumor-induced osteomalacia","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0003","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0004","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/ar.2014.5.0100","article-title":"Sinonasal phosphaturic mesenchymal tumor: case report and systematic review","volume":"5","author":"Deep","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0006","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","article-title":"Determination of the elimination half-life of fibroblast growth factor-23","volume":"92","author":"Khosravi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13139-015-0328-2","article-title":"Ga68-DOTA peptide PET\/CT to detect occult mesenchymal tumor-inducing osteomalacia: a case series of three patients","volume":"49","author":"Ho","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0009","first-page":"33","article-title":"Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"Mc","year":"1947","journal-title":"Q J Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0010","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","article-title":"The importance of whole body imaging in tumor-induced osteomalacia","volume":"96","author":"Chong","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0011","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12957-015-0763-7","article-title":"Tumour-induced osteomalacia: a literature review and a case report","volume":"14","author":"Dadoniene","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0013","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5732\/cjc.011.10013","article-title":"Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature","volume":"30","author":"Hu","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/07853890701689645","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"40","author":"Renkema","year":"2008","journal-title":"Ann Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jsbmb.2006.11.010","article-title":"The phosphatonins and the regulation of phosphate transport and vitamin D metabolism","volume":"103","author":"Sommer","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.5650040407","article-title":"Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0017","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-07-0485","article-title":"Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1","volume":"158","author":"Hannan","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/01913129109016242","article-title":"Review and update: oncogenic osteomalacia-rickets","volume":"15","author":"Weidner","year":"1991","journal-title":"Ultrastruct Pathol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0021","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia\u2013\u2013a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0022","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia","volume":"33","author":"Duet","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0024","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","article-title":"Tumor-induced hypophosphatemic rickets in an adolescent boy\u2013clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue","volume":"95","author":"Haeusler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0025","first-page":"56","article-title":"X-linked hypophosphatemia","volume":"9","author":"Meyer","year":"1989","journal-title":"Semin Nephrol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0026","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0027","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jcem.86.2.7302","article-title":"Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem","volume":"86","author":"Quarles","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0028","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(99)00170-2","article-title":"Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia","volume":"25","author":"Fukumoto","year":"1999","journal-title":"Bone"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0029","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0972-3919.119541","article-title":"Bone scintigraphic patterns in patients of tumor induced osteomalacia","volume":"28","author":"Sood","year":"2013","journal-title":"Indian J Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0030","first-page":"247","article-title":"Bone scan in tumor-induced osteomalacia","volume":"36","author":"Lee","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4158\/EP.12.1.35","article-title":"Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy","volume":"12","author":"Hodgson","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02985616","article-title":"Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia","volume":"18","author":"Kimizuka","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0033","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case","volume":"36","author":"Dupond","year":"2005","journal-title":"Bone"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","article-title":"Tumor-induced osteomalacia: a single center experience","volume":"17","author":"Jagtap","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13139-011-0095-7","article-title":"Using (18)F-FDG PET\/CT to detect an occult mesenchymal tumor causing oncogenic osteomalacia","volume":"45","author":"Seo","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0036","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","article-title":"Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report","volume":"27","author":"Garcia","year":"2002","journal-title":"Clin Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0037","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0038","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1148\/radiol.10090702","article-title":"Case 165: oncogenic osteomalacia","volume":"258","author":"Hendry","year":"2011","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0039","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","article-title":"Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography","volume":"22","author":"Hesse","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","article-title":"(68)Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia","volume":"35","author":"von Falck","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0041","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0042","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0043","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/rheumatology\/39.12.1415","article-title":"Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management","volume":"39","author":"Clunie","year":"2000","journal-title":"Rheumatology"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0044","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","article-title":"Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia","volume":"30","author":"Ogose","year":"2001","journal-title":"Skeletal Radiol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/729387","article-title":"Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a phosphaturic mesenchymal tumor at the tibia expressing periostin","author":"Hautmann","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0046","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc070347","article-title":"Radiofrequency ablation of a tumor causing oncogenic osteomalacia","volume":"357","author":"Hesse","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1067\/j.cpradiol.2018.06.005_bib0047","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Current Problems in Diagnostic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036301881830077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036301881830077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:45:14Z","timestamp":1759790714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036301881830077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S036301881830077X"],"URL":"https:\/\/doi.org\/10.1067\/j.cpradiol.2018.06.005","relation":{},"ISSN":["0363-0188"],"issn-type":[{"value":"0363-0188","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Diagnostic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/j.cpradiol.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}